These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29747328)

  • 1. [Successful management of tirofiban-induced acute profound thrombocytopenia after percutaneous coronary intervention with left main trunk lesions: a case report].
    Zhu YN; Cao XY; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):307-308. PubMed ID: 29747328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management].
    Agnelli D; Ottani F
    G Ital Cardiol (Rome); 2008 Feb; 9(2):137-43. PubMed ID: 18383777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirofiban-associated acute thrombocytopenia.
    Tuhta AG; Yeşildağ O; Köprülü D
    Acta Cardiol; 2006 Oct; 61(5):577-9. PubMed ID: 17117761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of tirofiban use after successful percutaneous coronary intervention for patients with moderate to high risk non-ST segment elevation acute coronary syndromes].
    Zhang Y; Gao CY; Zhu ZY; Liu HZ; Wang XP; Yang HH; Li MW; Wang XQ; Qi DT; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):731-5. PubMed ID: 24331798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.
    Dursunoglu D; Taskoylu O; Gür S; Sari I
    Asian Cardiovasc Thorac Ann; 2013 Feb; 21(1):74-6. PubMed ID: 23430426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound thrombocytopenia associated with tirofiban: case report and review of literature.
    Patel S; Patel M; Din I; Reddy CV; Kassotis J
    Angiology; 2005; 56(3):351-5. PubMed ID: 15889207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction.
    Rahman N; Jafary FH
    Tex Heart Inst J; 2010; 37(1):109-12. PubMed ID: 20200641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: a case report.
    Demirkan B; Guray Y; Guray U; Korkmaz S
    J Thromb Thrombolysis; 2006 Aug; 22(1):77-8. PubMed ID: 16786237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia.
    Dorsch MP; Montague D; Rodgers JE; Patterson C
    Pharmacotherapy; 2006 Mar; 26(3):423-7. PubMed ID: 16503724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
    Eryonucu B; Tuncer M; Erkoc R
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):503-5. PubMed ID: 15770438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
    Beiras-Fernandez A; Kowert A; Jiru P; Weis M; Spannagl M; Reichart B; Schmoeckel M
    Ann Thorac Surg; 2009 Feb; 87(2):629-31. PubMed ID: 19161801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang Y; Gao C; Liu H; Wang X; Yang H; Li M; Wang X; Zhu Z; Hu D
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):289-94. PubMed ID: 23551127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y; Guo J; Zheng Y; Zang H; Su X; Wang Y; Chen S; Jiang T; Yang P; Chen J; Jiang D; Jing Q; Liang Z; Liu H; Zhao X; Li J; Li Y; Xu B; Stone GW;
    JAMA; 2015 Apr; 313(13):1336-46. PubMed ID: 25775052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Tang X; Li R; Jing Q; Liu Y; Liu P
    PLoS One; 2015; 10(6):e0129718. PubMed ID: 26067296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short- or long-outcome of early tirofiban in ST-segment elevated acute myocardial infarction undergoing elective percutaneous coronary intervention].
    Zhang Y; Gao C; Li M; Liu H; Wang X; Yang H; Wang X; Zhu Z; Hu D
    Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):273-7. PubMed ID: 24857299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of upstream tirofiban versus downstream tirofiban on platelet aggregation and clinical outcomes in patients with high-risk acute coronary syndromes undergoing percutaneous coronary interventions].
    Xie Y; Liu T; Zhou YJ; Ma HY; Guo YH; Li YP; Cheng WJ; Liu YY; Zhao YX; Shi DM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):39-43. PubMed ID: 19671350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tirofiban improved the prognosis of senior acute coronary syndrome patients received percutaneous coronary intervention].
    Zhang YX; Lu CY; Zhou SH; Xue Q; Gao L; Tian JW; Gao W; Chen R; Zhai JY; Li LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Dec; 23(12):727-30. PubMed ID: 22153009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.
    Adamo M; Ariotti S; Costa F; Curello S; Moschovitis A; de Vries T; White HD; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1667-76. PubMed ID: 27539685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.